SCHEMBL8261009

SCHEMBL8261009

CN1CCN(Cc2ccc(C(=O)Cl)cc2)CC1.CN1CCN(Cc2ccc(C(=O)Nc3cccc(Nc4nccc(-c5cccnc5)n4)c3)cc2)CC1

nearest known ligand 0.94

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 19/20 0.94
▸ BCR P11274 16/20 0.94
▸ PDGFRA P16234 6/20 0.94
▸ PDGFRB P09619 5/20 0.94
▸ SRC P12931 4/20 0.94
▸ SYK P43405 2/20 0.94
▸ KIT P10721 8/20 0.77
▸ ABL2 P42684 5/20 0.77
▸ LYN P07948 2/20 0.77
▸ PLK4 O00444 1/20 0.77
▸ DDX3X O00571 1/20 0.77
▸ GAK O14976 1/20 0.77
▸ SLC22A2 O15244 1/20 0.77
▸ MAPK13 O15264 1/20 0.77
▸ CA12 O43570 1/20 0.77
▸ SLC22A3 O75751 1/20 0.77
▸ ABCB11 O95342 1/20 0.77
▸ EGFR P00533 1/20 0.77
▸ CA1 P00915 1/20 0.77
▸ CA2 P00918 1/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9485 0.97 ABL1 (1.00) ABL1BCRPDGFRAPDGFRBSRC
SCHEMBL3866664 0.94 ABL1 (0.94) ABL1BCRPDGFRAPDGFRBSRC
SCHEMBL3867814 0.91 ABL1 (0.88) ABL1BCRPDGFRAPDGFRBSRC
Imatinib SCHEMBL8261481 0.90 ABL1 (0.94) ABL1BCRPDGFRAPDGFRBSRC
SCHEMBL4897571 0.90 ABL1 (0.86) ABL1BCRPDGFRAPDGFRBSRC
SCHEMBL4902292 0.89 ABL1 (0.86) ABL1BCRPDGFRAPDGFRBSRC
SCHEMBL26358567 0.89 ABL1 (0.85) ABL1BCRPDGFRAPDGFRBSRC
SCHEMBL3858318 0.89 ABL1 (0.84) ABL1BCRPDGFRAPDGFRBSRC
SCHEMBL13038805 0.87 ABL1 (0.82) ABL1BCRPDGFRAPDGFRBSRC
Imatinib SCHEMBL2236091 0.87 ABL1 (1.00) ABL1BCRPDGFRAPDGFRBSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0564409-B1 Pyrimidin derivatives and process for their preparation NOVARTIS AG (CH) 2000-01-19 — — EP disclosed
EP-0564409-A1 Pyrimidin derivatives and process for their preparation CIBA-GEIGY AG (CH) 1993-10-06 — — EP disclosed
Send feedback